Author:
Bao Fang,Wan Wei,He Ting,Qi Feifei,Liu Guanghua,Hu Kai,Lu Xin-an,Yang Ping,Dong Fei,Wang Jing,Jing Hongmei
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference25 articles.
1. Chaganti S, Illidge T, Barrington S, Mckay P, Linton K, Cwynarski K et al. Guidelines for the management of diffuse large B-cell lymphoma. Br J Haematol. 2016; 174:43–56.
2. Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood. 2015;125:22.
3. Ng AK. Diffuse large B-cell lymphoma. Semin Radiat Oncol. 2007;17:169–75.
4. Seshadri T, Stakiw J, Pintilie M, Keating A, Crump M, Kuruvilla J. Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy. Hematology. 2008;13:261–6.
5. Crump M, Neelapu SS, Farooq U, Van DNE, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;16:S101–S101.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献